Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMoleculin Biotech, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.51 | -$2.51 | -$2.51 |
| Q2 2024 | 1 | -$2.44 | -$2.44 | -$2.44 |
| Q3 2024 | 1 | -$1.26 | -$1.26 | -$1.26 |
| Q1 2025 | 1 | -$1.26 | -$1.26 | -$1.26 |
| Q2 2025 | 1 | -$1.25 | -$1.25 | -$1.25 |
| Q3 2025 | 1 | -$1.25 | -$1.25 | -$1.25 |
| Q4 2025 | 1 | -$1.25 | -$1.25 | -$1.25 |
Moleculin Biotech, Inc. Earnings Date And Information
Moleculin Biotech, Inc. last posted its earnings results on Monday, November 11th, 2024. The company reported $-2.85 earnings per share for the quarter, missing analysts' consensus estimates of $-2.44 by $0.41. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Moleculin Biotech, Inc. has generated $-15 earnings per share over the last year ($-15.07 diluted earnings per share) and currently has a price-to-earnings ratio of -0.22. Moleculin Biotech, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based on prior year's report dates.
Moleculin Biotech, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$2.85 | $0 | $0 | ||
| 08/13/2024 | Q2 2024 | -$2.10 | -$1.70 | 0.4 | $0 | $0 |
| 05/10/2024 | Q1 2024 | -$3.59 | -$2.02 | 1.57 | $0 | |
| 04/26/2024 | Q4 2023 | -$5.13 | $406,000 | |||
| 11/13/2023 | Q3 2023 | -$3.15 | -$2.82 | 0.33 | $0 | |
| 08/10/2023 | Q2 2023 | -$3.02 | $0 | |||
| 05/10/2023 | Q1 2023 | -$3.86 | $0 | |||
| 03/22/2023 | Q4 2022 | -$4.20 | -$2.95 | 1.25 | $0 | |
| 11/10/2022 | Q3 2022 | -$4.05 | -$4.49 | -0.44 | $0 | |
| 08/12/2022 | Q2 2022 | -$3.56 | $0 | |||
| 05/11/2022 | Q1 2022 | -$3.15 | -$3.50 | -0.35 | $0 | |
| 03/24/2022 | Q4 2021 | -$1.48 | $0 | |||
| 11/10/2021 | Q3 2021 | -$2.30 | $0 | |||
| 08/11/2021 | Q2 2021 | -$2.24 | $0 | |||
| 05/12/2021 | Q1 2021 | -$3.90 | -$3.06 | 0.84 | $0 | |
| 03/24/2021 | Q4 2020 | -$0.58 | -$3.43 | -2.85 | $0 | |
| 11/12/2020 | Q3 2020 | -$4.97 | $0 | |||
| 08/12/2020 | Q2 2020 | -$8.09 | -$15.30 | -7.21 | $0 | |
| 05/11/2020 | Q1 2020 | -$8.99 | -$2.18 | 6.81 | $0 | |
| 03/19/2020 | Q4 2019 | -$10.79 | -$7.47 | 3.32 | $0 |
Moleculin Biotech, Inc. Earnings: FAQ's
When is Moleculin Biotech, Inc.'s earnings date?
Moleculin Biotech, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates.
How can I listen to Moleculin Biotech, Inc.'s earnings conference
call?
The conference call for Moleculin Biotech, Inc.'s latest earnings report can be listened to online.
How can I read Moleculin Biotech, Inc.'s conference call transcript?
The conference call transcript for Moleculin Biotech, Inc.'s latest earnings report can be read online.
How much profit does Moleculin Biotech, Inc. generate each year?
Moleculin Biotech, Inc. (:MBRX) has a recorded net income of $0. Moleculin Biotech, Inc. has generated $-15.07 earnings per share over the last four quarters.
What is Moleculin Biotech, Inc.'s price-to-earnings ratio?
Moleculin Biotech, Inc. (:MBRX) has a price-to-earnings ratio of -0.22 and price/earnings-to-growth ratio is 0.87.